Differentiation of basal insulins in randomized clinical trials in T2DM subjects: a model-based meta-analysis of HbA1c and hypoglycemic event rates

被引：0
|
作者：
Vaddady, Pavan [1 ]
Lovern, Mark [2 ]
Lommerse, Jos [2 ]
Fancourt, Craig [1 ]
Kandala, Bhargava [1 ]
Mandema, Jaap [2 ]
Gheyas, Ferdous [1 ]
Kerbusch, Thomas [2 ]
Visser, Sandra A. G. [1 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] Certara Strateg Consultancy, Kenilworth, NJ USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
T-032
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of basal insulins in people with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials
    Dehghani, Mohsen
    Sadeghi, Masoumeh
    Barzkar, Farzaneh
    Maghsoomi, Zohreh
    Janani, Leila
    Motevalian, Seyed Abbas
    Loke, Yoon K.
    Ismail-Beigi, Faramarz
    Baradaran, Hamid Reza
    Khamseh, Mohammad E.
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [42] Contribution of fasting and postprandial plasma glucose to HbA1c in people with type 2 diabetes on basal-bolus insulin: a meta-analysis of insulin lispro clinical trials
    Liao, B.
    Chen, Y.
    Chigutsa, F.
    de Oliveira, C. Piras
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S332 - S332
  • [43] Effects of testosterone supplementation therapy on lipid metabolism in hypogonadal men with T2DM: a meta-analysis of randomized controlled trials
    Zhang, K. -S.
    Zhao, M. -J.
    An, Q.
    Jia, Y. -F.
    Fu, L. -L.
    Xu, J. -F.
    Gu, Y. -Q.
    ANDROLOGY, 2018, 6 (01) : 37 - 46
  • [44] Achievement of Goal A1C (<7%) by US Patients with T2DM on Basal Insulin in Both Randomized, Controlled Trials (RCTs) and in Clinical Practice
    Blonde, Lawrence
    Brunton, Stephen A.
    Chava, Pavan
    Dalal, Mehul
    Zhou, Rong
    Meyers, Juliana L.
    Davis, Keith L.
    Digenio, Andres
    DIABETES, 2014, 63 : A235 - A235
  • [45] In uncontrolled T2DM treated with a basal-bolus insulin regimen, weekly icodec was noninferior to daily glargine for HbA1c at 26 wk
    Belal, Heiba
    Gandhi, Gunjan Y.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (08) : JC94 - JC94
  • [46] Meta-analysis of HbA1c-Lowering Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Combination with Insulin in T2DM Patients
    Yang, Jin
    Tian, Qing
    Tang, Yuexin
    Shah, Arvind K.
    Zhang, Ruya
    Chen, Guojuan
    Zhang, Ye
    Rajpathak, Swapnil
    Hong, Tianpei
    DIABETES, 2018, 67
  • [47] Efficacy of Glucagon-like Peptide-1 Receptor Agonists in Overweight/Obese and/or T2DM Adolescents: A Meta-analysis Based on Randomized Controlled Trials
    Dai, Min
    Dai, Senjie
    Gu, Lihu
    Xiang, Zhiyi
    Xu, Anyi
    Lu, Siyu
    Yang, Yang
    Zhou, Cong
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2024, 16 (03) : 323 - 333
  • [48] The impact of case management interventions on blood glucose control (HbA1c) in diabetes: Results of a meta-analysis of clinical trials
    Welch, Garry
    Garb, Jane
    Stark, Alan
    Gabbay, Robert A.
    Zagarins, Sofija
    Lendel, Irina
    DIABETES, 2008, 57 : A248 - A249
  • [49] A Model-based Meta-analysis Study on the Quantitative Relationship of Pharmacokinetics: Fasting Plasma Glucose corrected Urinary Glucose Excretion-HbA1c for Sodium Glucose co-Transporter-2 Inhibitors in T2DM Patients
    Zhou, Jiawei
    Ren, Yupeng
    Liu, Dongyang
    Hu, Bei
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S11 - S11
  • [50] Dipeptidyl peptidase-4 inhibitors and HbA1c target of &lt;7% in type 2 diabetes: meta-analysis of randomized controlled trials
    Esposito, K.
    Cozzolino, D.
    Bellastella, G.
    Maiorino, M. I.
    Chiodini, P.
    Ceriello, A.
    Giugliano, D.
    DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 594 - 603
12345